311 related articles for article (PubMed ID: 12132977)
1. Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial.
Ahluwalia JS; Harris KJ; Catley D; Okuyemi KS; Mayo MS
JAMA; 2002 Jul 24-31; 288(4):468-74. PubMed ID: 12132977
[TBL] [Abstract][Full Text] [Related]
2. Bupropion for smoking cessation in African American light smokers: a randomized controlled trial.
Cox LS; Nollen NL; Mayo MS; Choi WS; Faseru B; Benowitz NL; Tyndale RF; Okuyemi KS; Ahluwalia JS
J Natl Cancer Inst; 2012 Feb; 104(4):290-8. PubMed ID: 22282543
[TBL] [Abstract][Full Text] [Related]
3. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
[TBL] [Abstract][Full Text] [Related]
4. A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.
Robles GI; Singh-Franco D; Ghin HL
Clin Ther; 2008 May; 30(5):800-12. PubMed ID: 18555928
[TBL] [Abstract][Full Text] [Related]
5. Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial.
Faseru B; Nollen NL; Mayo MS; Krebill R; Choi WS; Benowitz NL; Tyndale RF; Okuyemi KS; Ahluwalia JS; Sanderson Cox L
Addict Behav; 2013 Mar; 38(3):1796-803. PubMed ID: 23254230
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
[TBL] [Abstract][Full Text] [Related]
7. Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.
Cox LS; Faseru B; Mayo MS; Krebill R; Snow TS; Bronars CA; Nollen NL; Choi WS; Okuyemi KS; Salzman GA; Benowitz NL; Tyndale RF; Ahluwalia JS
Trials; 2011 Jan; 12():22. PubMed ID: 21266057
[TBL] [Abstract][Full Text] [Related]
8. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
Ebbert JO; Hatsukami DK; Croghan IT; Schroeder DR; Allen SS; Hays JT; Hurt RD
JAMA; 2014 Jan; 311(2):155-63. PubMed ID: 24399554
[TBL] [Abstract][Full Text] [Related]
9. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.
Tonstad S; Farsang C; Klaene G; Lewis K; Manolis A; Perruchoud AP; Silagy C; van Spiegel PI; Astbury C; Hider A; Sweet R
Eur Heart J; 2003 May; 24(10):946-55. PubMed ID: 12714026
[TBL] [Abstract][Full Text] [Related]
10. Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion.
Harris KJ; Okuyemi KS; Catley D; Mayo MS; Ge B; Ahluwalia JS
Prev Med; 2004 Apr; 38(4):498-502. PubMed ID: 15020185
[TBL] [Abstract][Full Text] [Related]
11. Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial.
Nanovskaya TN; Oncken C; Fokina VM; Feinn RS; Clark SM; West H; Jain SK; Ahmed MS; Hankins GDV
Am J Obstet Gynecol; 2017 Apr; 216(4):420.e1-420.e9. PubMed ID: 27890648
[TBL] [Abstract][Full Text] [Related]
12. Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial.
Ware OD; Sweeney MM; Cunningham C; Umbricht A; Stitzer M; Dunn KE
JAMA Netw Open; 2023 Mar; 6(3):e232278. PubMed ID: 36920397
[TBL] [Abstract][Full Text] [Related]
13. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.
Tønnesen P; Tonstad S; Hjalmarson A; Lebargy F; Van Spiegel PI; Hider A; Sweet R; Townsend J
J Intern Med; 2003 Aug; 254(2):184-92. PubMed ID: 12859700
[TBL] [Abstract][Full Text] [Related]
14. The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion.
Catley D; Harris KJ; Okuyemi KS; Mayo MS; Pankey E; Ahluwalia JS
Nicotine Tob Res; 2005 Dec; 7(6):859-70. PubMed ID: 16298721
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
[TBL] [Abstract][Full Text] [Related]
16. The impact of perceived treatment assignment on smoking cessation outcomes among African-American smokers.
Thomas JL; Guo H; Lynam IM; Powell JN; Okuyemi KS; Bronars CA; Ahluwalia JS
J Gen Intern Med; 2008 Sep; 23(9):1361-6. PubMed ID: 18587620
[TBL] [Abstract][Full Text] [Related]
17. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J
Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727
[TBL] [Abstract][Full Text] [Related]
18. Changes in health-related quality of life with smoking cessation treatment.
Hays JT; Croghan IT; Baker CL; Cappelleri JC; Bushmakin AG
Eur J Public Health; 2012 Apr; 22(2):224-9. PubMed ID: 20884658
[TBL] [Abstract][Full Text] [Related]
19. Use of sustained-release bupropion in specific patient populations for smoking cessation.
Tonstad S
Drugs; 2002; 62 Suppl 2():37-43. PubMed ID: 12109934
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.
Dalsgareth OJ; Hansen NC; Søes-Petersen U; Evald T; Høegholm A; Barber J; Vestbo J
Nicotine Tob Res; 2004 Feb; 6(1):55-61. PubMed ID: 14982688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
